Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Lucy, I think were getting closer, look ma, password prompt.

<< Previous

Bullboard Posts

Next >>

Comment by Dude51on Feb 19, 2021 7:45pm

156 Views

Post# 32616734

RE:RE:Lucy, I think were getting closer, look ma, password prompt.

Exactly shiit for brains, it just shows were coming back and you will finally be able to sell all your shares. Will you finally leave for good or try and save more of us beacuse we know its just a shell company? Shiit for brains we are still waiting for a link to your proof or poof of this shell company.
Here's a tip, were in tight with the Salzman Group, wake up, smell the year...
GLTA

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"